| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.631 | 0.004 | 0.631 | Hedgehog signaling inhibitor | 0.321 0.005 DBMET03659 0.455 0.004 DBMET03660 0.26 0.006 DBMET03663 0.143 0.027 DBMET03661 0.184 0.014 DBMET03662 | ||
| 0.52 | 0.004 | 0.52 | Cyclooxygenase inhibitor | 0.481 0.005 DBMET03659 0.48 0.005 DBMET03660 0.465 0.005 DBMET03663 0.348 0.011 DBMET03661 0.348 0.011 DBMET03662 | ||
| 0.473 | 0.004 | 0.473 | Cyclooxygenase 2 inhibitor | 0.436 0.005 DBMET03659 0.434 0.005 DBMET03660 0.421 0.005 DBMET03663 0.336 0.01 DBMET03661 0.335 0.01 DBMET03662 | ||
| 0.455 | 0.04 | 0.471 | Thyroid hormone beta antagonist | 0.386 0.058 DBMET03659 0.367 0.063 DBMET03660 0.471 0.037 DBMET03663 | DBMET03663 | |
| 0.448 | 0.035 | 0.448 | MAP kinase kinase 6 inhibitor | 0.389 0.065 DBMET03659 0.366 0.08 DBMET03660 0.369 0.079 DBMET03663 0.247 0.195 DBMET03661 0.226 0.225 DBMET03662 | ||
| 0.432 | 0.047 | 0.461 | Thyroid hormone antagonist | 0.377 0.064 DBMET03659 0.361 0.069 DBMET03660 0.461 0.04 DBMET03663 | DBMET03663 | |
| 0.389 | 0.008 | 0.389 | Cyclooxygenase 1 inhibitor | 0.356 0.009 DBMET03659 0.378 0.008 DBMET03660 0.351 0.01 DBMET03663 0.223 0.027 DBMET03661 0.226 0.026 DBMET03662 | ||
| 0.324 | 0.004 | 0.324 | Smo receptor antagonist | 0.095 0.009 DBMET03659 0.128 0.005 DBMET03660 0.071 0.015 DBMET03663 | ||
| 0.301 | 0.014 | 0.445 | Heat shock protein 90 alpha antagonist | 0.445 0.005 DBMET03659 0.272 0.02 DBMET03660 0.408 0.005 DBMET03663 0.166 0.073 DBMET03661 | DBMET03659 | |
| 0.314 | 0.031 | 0.314 | EphB2 antagonist | 0.263 0.05 DBMET03659 0.24 0.062 DBMET03660 0.228 0.07 DBMET03663 | ||
| 0.351 | 0.087 | 0.37 | Antiobesity | 0.213 0.194 DBMET03659 0.337 0.094 DBMET03660 0.239 0.167 DBMET03661 0.37 0.078 DBMET03662 | DBMET03662 | |
| 0.358 | 0.116 | 0.578 | Cyclophilin D inhibitor | 0.29 0.172 DBMET03659 0.415 0.083 DBMET03660 0.27 0.191 DBMET03663 0.478 0.057 DBMET03661 0.578 0.031 DBMET03662 | DBMET03662 | |
| 0.273 | 0.035 | 0.273 | Non-steroidal antiinflammatory agent | 0.263 0.038 DBMET03659 0.216 0.059 DBMET03660 0.212 0.062 DBMET03663 0.265 0.037 DBMET03661 0.192 0.078 DBMET03662 | ||
| 0.35 | 0.13 | 0.35 | Transcription factor inhibitor | 0.277 0.169 DBMET03659 0.22 0.209 DBMET03660 0.291 0.16 DBMET03663 | ||
| 0.24 | 0.031 | 0.24 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.166 0.054 DBMET03659 0.207 0.04 DBMET03660 0.189 0.045 DBMET03663 | ||
| 0.233 | 0.027 | 0.237 | Interleukin 6 antagonist | 0.228 0.028 DBMET03659 0.206 0.038 DBMET03660 0.21 0.035 DBMET03663 0.237 0.026 DBMET03661 0.218 0.032 DBMET03662 | DBMET03661 | |
| 0.21 | 0.008 | 0.21 | Pregnane X receptor agonist | 0.157 0.042 DBMET03659 0.193 0.013 DBMET03660 0.168 0.028 DBMET03663 | ||
| 0.324 | 0.124 | 0.333 | Analgesic | 0.231 0.201 DBMET03659 0.333 0.118 DBMET03660 | DBMET03660 | |
| 0.24 | 0.043 | 0.24 | LIM domain kinase 1 inhibitor | 0.136 0.113 DBMET03659 0.19 0.068 DBMET03660 0.157 0.091 DBMET03663 | ||
| 0.234 | 0.063 | 0.248 | Peptidyltransferase inhibitor | 0.226 0.07 DBMET03659 0.243 0.056 DBMET03660 0.243 0.056 DBMET03663 0.235 0.062 DBMET03661 0.248 0.052 DBMET03662 | DBMET03662 | |
| 0.228 | 0.06 | 0.228 | MAP kinase kinase 3 inhibitor | 0.203 0.114 DBMET03659 0.196 0.133 DBMET03663 | ||
| 0.298 | 0.133 | 0.393 | 15-Lipoxygenase inhibitor | 0.346 0.102 DBMET03659 0.279 0.144 DBMET03660 0.393 0.077 DBMET03663 | DBMET03663 | |
| 0.17 | 0.012 | 0.17 | I kappa B kinase inhibitor | 0.134 0.021 DBMET03659 0.138 0.019 DBMET03660 0.104 0.035 DBMET03663 | ||
| 0.22 | 0.07 | 0.22 | MAP kinase kinase 2 inhibitor | 0.187 0.091 DBMET03660 | ||
| 0.169 | 0.02 | 0.169 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.081 DBMET03659 0.141 0.042 DBMET03660 0.14 0.043 DBMET03663 0.114 0.084 DBMET03662 | ||
| 0.15 | 0.005 | 0.152 | Glutamate (mGluR group III) agonist | 0.152 0.005 DBMET03659 0.051 0.023 DBMET03660 0.136 0.005 DBMET03663 0.065 0.016 DBMET03661 | DBMET03659 | |
| 0.184 | 0.039 | 0.184 | Sodium channel blocker | 0.123 0.081 DBMET03660 | ||
| 0.149 | 0.005 | 0.149 | I kappa B kinase 2 inhibitor | 0.113 0.009 DBMET03659 0.107 0.01 DBMET03660 0.092 0.015 DBMET03663 | ||
| 0.152 | 0.014 | 0.152 | Cannabinoid receptor antagonist | 0.111 0.024 DBMET03660 | ||
| 0.157 | 0.022 | 0.157 | CDK3/cyclin E inhibitor | 0.155 0.023 DBMET03659 0.148 0.028 DBMET03660 0.127 0.046 DBMET03663 0.099 0.09 DBMET03662 | ||
| 0.134 | 0.005 | 0.134 | Liver X receptor agonist | 0.107 0.007 DBMET03659 0.113 0.006 DBMET03660 0.105 0.007 DBMET03663 0.057 0.018 DBMET03661 0.066 0.014 DBMET03662 | ||
| 0.264 | 0.135 | 0.281 | Toll-Like receptor 7 agonist | 0.281 0.123 DBMET03659 0.262 0.137 DBMET03660 0.242 0.154 DBMET03661 0.258 0.141 DBMET03662 | DBMET03659 | |
| 0.148 | 0.019 | 0.148 | Interleukin 2 antagonist | 0.13 0.033 DBMET03659 0.117 0.05 DBMET03660 0.102 0.085 DBMET03663 0.109 0.065 DBMET03661 0.11 0.063 DBMET03662 | ||
| 0.194 | 0.074 | 0.194 | Focal adhesion kinase 2 inhibitor | |||
| 0.126 | 0.008 | 0.126 | MAP kinase kinase 9 inhibitor | 0.061 0.029 DBMET03659 0.055 0.04 DBMET03660 0.069 0.021 DBMET03663 | ||
| 0.122 | 0.004 | 0.122 | Liver X receptor beta agonist | 0.083 0.005 DBMET03659 0.104 0.005 DBMET03660 0.073 0.006 DBMET03663 | ||
| 0.17 | 0.055 | 0.307 | Heat shock protein 90 antagonist | 0.307 0.009 DBMET03659 0.16 0.064 DBMET03660 0.259 0.018 DBMET03663 0.163 0.062 DBMET03661 | DBMET03659 | |
| 0.256 | 0.143 | 0.274 | Toll-Like receptor agonist | 0.274 0.128 DBMET03659 0.255 0.144 DBMET03660 0.237 0.16 DBMET03661 0.251 0.147 DBMET03662 | DBMET03659 | |
| 0.117 | 0.004 | 0.117 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.037 DBMET03659 0.077 0.02 DBMET03660 0.073 0.024 DBMET03663 | ||
| 0.192 | 0.083 | 0.202 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.135 0.134 DBMET03659 0.202 0.075 DBMET03660 | DBMET03660 | |
| 0.166 | 0.057 | 0.166 | Vascular endothelial growth factor 3 antagonist | 0.147 0.069 DBMET03659 0.12 0.095 DBMET03660 | ||
| 0.13 | 0.022 | 0.13 | Lanosterol 14 alpha demethylase inhibitor | 0.098 0.059 DBMET03660 0.1 0.055 DBMET03663 | ||
| 0.243 | 0.139 | 0.257 | Thioredoxin glutathione reductase inhibitor | 0.236 0.144 DBMET03659 0.224 0.152 DBMET03660 0.257 0.129 DBMET03663 | DBMET03663 | |
| 0.154 | 0.051 | 0.154 | Sodium channel (voltage-gated) blocker | |||
| 0.12 | 0.019 | 0.12 | Prostaglandin-E synthase inhibitor | 0.098 0.028 DBMET03660 | ||
| 0.135 | 0.035 | 0.135 | MAP kinase 8 inhibitor | 0.094 0.068 DBMET03659 0.092 0.07 DBMET03660 0.091 0.072 DBMET03663 | ||
| 0.104 | 0.006 | 0.104 | Growth hormone secretagogue receptor agonist | 0.064 0.015 DBMET03659 0.076 0.012 DBMET03660 0.06 0.016 DBMET03663 | ||
| 0.154 | 0.057 | 0.154 | Alkaline phosphatase inhibitor | 0.117 0.09 DBMET03659 0.142 0.065 DBMET03660 | ||
| 0.112 | 0.022 | 0.112 | Focal adhesion kinase 1 inhibitor | 0.096 0.033 DBMET03659 0.09 0.039 DBMET03660 0.085 0.044 DBMET03663 | ||
| 0.164 | 0.077 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.152 0.101 DBMET03659 0.154 0.098 DBMET03660 | ||
| 0.156 | 0.069 | 0.159 | Insulin secretagoues | 0.124 0.105 DBMET03659 0.147 0.078 DBMET03660 0.144 0.081 DBMET03663 0.127 0.101 DBMET03661 0.159 0.066 DBMET03662 | DBMET03662 | |
| 0.091 | 0.005 | 0.091 | Liver X receptor alpha agonist | 0.058 0.013 DBMET03659 0.084 0.006 DBMET03660 0.07 0.009 DBMET03663 | ||
| 0.097 | 0.012 | 0.097 | Glycine transporter inhibitor | 0.049 0.032 DBMET03660 0.055 0.028 DBMET03663 | ||
| 0.211 | 0.126 | 0.25 | Streptokinase A inhibitor | 0.163 0.16 DBMET03659 0.211 0.126 DBMET03660 0.25 0.103 DBMET03663 | DBMET03663 | |
| 0.089 | 0.005 | 0.089 | Liver X receptor antagonist | 0.074 0.006 DBMET03659 0.074 0.006 DBMET03660 0.074 0.006 DBMET03663 0.034 0.019 DBMET03661 0.036 0.016 DBMET03662 | ||
| 0.1 | 0.016 | 0.1 | Cannabinoid CB1 receptor antagonist | 0.055 0.051 DBMET03660 | ||
| 0.129 | 0.046 | 0.129 | MAP kinase kinase kinase inhibitor | 0.092 0.075 DBMET03659 0.106 0.061 DBMET03660 | ||
| 0.1 | 0.019 | 0.1 | Cannabinoid CB2 receptor agonist | |||
| 0.179 | 0.101 | 0.179 | Histone acetyltransferase inhibitor | |||
| 0.126 | 0.049 | 0.126 | Granulocyte macrophage colony stimulating factor antagonist | 0.089 0.086 DBMET03659 | ||
| 0.124 | 0.047 | 0.124 | MAP kinase 9 inhibitor | |||
| 0.295 | 0.221 | 0.519 | Antiinflammatory | 0.289 0.225 DBMET03659 0.427 0.123 DBMET03660 0.481 0.096 DBMET03661 0.519 0.08 DBMET03662 | DBMET03662 | |
| 0.127 | 0.053 | 0.139 | Interleukin 8 antagonist | 0.101 0.095 DBMET03659 0.101 0.094 DBMET03660 0.139 0.042 DBMET03663 | DBMET03663 | |
| 0.111 | 0.038 | 0.111 | ABCA1 expression enhancer | 0.098 0.053 DBMET03659 0.108 0.041 DBMET03660 0.092 0.062 DBMET03663 0.088 0.07 DBMET03661 0.096 0.056 DBMET03662 | ||
| 0.081 | 0.011 | 0.081 | DNA helicase inhibitor | 0.079 0.012 DBMET03659 0.08 0.011 DBMET03660 0.078 0.012 DBMET03663 0.061 0.027 DBMET03661 0.062 0.025 DBMET03662 | ||
| 0.072 | 0.004 | 0.072 | Liver X receptor beta antagonist | 0.059 0.005 DBMET03659 0.066 0.005 DBMET03660 0.067 0.005 DBMET03663 | ||
| 0.146 | 0.08 | 0.178 | Diuretic | 0.137 0.088 DBMET03659 0.178 0.055 DBMET03663 | DBMET03663 | |
| 0.075 | 0.009 | 0.075 | Carnitine palmitoyltransferase 1B inhibitor | 0.062 0.016 DBMET03659 0.07 0.011 DBMET03660 0.065 0.014 DBMET03663 0.051 0.027 DBMET03661 0.058 0.02 DBMET03662 | ||
| 0.071 | 0.006 | 0.071 | Glutamate (mGluR4) agonist | 0.043 0.014 DBMET03659 0.056 0.009 DBMET03663 | ||
| 0.106 | 0.042 | 0.106 | Potassium channel activator | 0.094 0.055 DBMET03663 | ||
| 0.073 | 0.009 | 0.073 | Glycine transporter 1 inhibitor | 0.038 0.022 DBMET03659 0.046 0.017 DBMET03660 0.047 0.017 DBMET03663 | ||
| 0.091 | 0.033 | 0.091 | Nav1.8 sodium channel blocker | 0.073 0.051 DBMET03659 0.086 0.037 DBMET03660 0.068 0.059 DBMET03662 | ||
| 0.14 | 0.083 | 0.173 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.14 0.083 DBMET03659 0.173 0.057 DBMET03660 | DBMET03660 | |
| 0.176 | 0.122 | 0.177 | ErbB-1 antagonist | 0.172 0.129 DBMET03660 0.177 0.121 DBMET03663 | DBMET03663 | |
| 0.085 | 0.031 | 0.085 | MAP kinase kinase 8 inhibitor | 0.065 0.054 DBMET03659 0.063 0.057 DBMET03663 | ||
| 0.121 | 0.068 | 0.121 | MAP kinase 12 inhibitor | |||
| 0.059 | 0.006 | 0.059 | Cathepsin F inhibitor | 0.049 0.014 DBMET03659 0.051 0.011 DBMET03660 0.05 0.013 DBMET03663 0.043 0.025 DBMET03661 0.045 0.021 DBMET03662 | ||
| 0.107 | 0.055 | 0.107 | Cyclin-dependent kinase 9 inhibitor | 0.106 0.057 DBMET03660 | ||
| 0.073 | 0.022 | 0.09 | Cannabinoid CB2 receptor antagonist | 0.09 0.017 DBMET03660 | DBMET03660 | |
| 0.075 | 0.024 | 0.158 | Heat shock protein 90 beta antagonist | 0.158 0.004 DBMET03659 0.085 0.018 DBMET03660 0.064 0.034 DBMET03663 | DBMET03659 | |
| 0.055 | 0.005 | 0.055 | Liver X receptor alpha antagonist | 0.05 0.005 DBMET03659 0.051 0.005 DBMET03660 0.051 0.005 DBMET03663 0.029 0.02 DBMET03661 0.031 0.017 DBMET03662 | ||
| 0.063 | 0.013 | 0.063 | Growth hormone secretagogue receptor antagonist | 0.035 0.025 DBMET03660 | ||
| 0.12 | 0.074 | 0.12 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET03660 | ||
| 0.111 | 0.065 | 0.111 | MAP kinase 13 inhibitor | |||
| 0.07 | 0.024 | 0.071 | CC chemokine 2 receptor antagonist | 0.064 0.029 DBMET03659 0.071 0.024 DBMET03660 | DBMET03660 | |
| 0.052 | 0.007 | 0.052 | ATR kinase inhibitor | 0.032 0.024 DBMET03659 0.031 0.027 DBMET03660 0.032 0.025 DBMET03663 | ||
| 0.087 | 0.042 | 0.087 | Vanilloid antagonist | |||
| 0.177 | 0.135 | 0.202 | Nitric-oxide synthase stimulant | 0.191 0.105 DBMET03659 0.2 0.089 DBMET03660 0.202 0.085 DBMET03663 | DBMET03663 | |
| 0.069 | 0.027 | 0.069 | Phosphodiesterase 4C inhibitor | |||
| 0.077 | 0.037 | 0.077 | Cannabinoid receptor agonist | |||
| 0.063 | 0.023 | 0.063 | Factor Xa inhibitor | 0.043 0.035 DBMET03660 | ||
| 0.127 | 0.088 | 0.127 | Activin receptor-like kinase 2 inhibitor | |||
| 0.112 | 0.075 | 0.112 | TRKA antagonist | |||
| 0.193 | 0.159 | 0.222 | 12-Lipoxygenase inhibitor | 0.219 0.131 DBMET03659 0.205 0.147 DBMET03660 0.222 0.129 DBMET03663 | DBMET03663 | |
| 0.136 | 0.103 | 0.145 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.145 0.083 DBMET03659 | DBMET03659 | |
| 0.056 | 0.023 | 0.056 | Alpha 1b adrenoreceptor agonist | 0.049 0.039 DBMET03659 0.051 0.033 DBMET03660 0.054 0.027 DBMET03663 | ||
| 0.038 | 0.006 | 0.038 | Hexokinase stimulant | 0.018 0.016 DBMET03659 0.02 0.014 DBMET03660 0.02 0.014 DBMET03663 | ||
| 0.037 | 0.005 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.021 0.008 DBMET03660 0.023 0.007 DBMET03663 | ||
| 0.057 | 0.026 | 0.057 | Phosphodiesterase 7A inhibitor | |||
| 0.055 | 0.024 | 0.055 | Aldosterone antagonist | |||
| 0.066 | 0.037 | 0.066 | Kallikrein 7 inhibitor | |||
| 0.125 | 0.097 | 0.146 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.146 0.08 DBMET03660 | DBMET03660 | |
| 0.276 | 0.248 | 0.276 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.085 | 0.057 | 0.085 | Bcr-Abl kinase inhibitor | |||
| 0.078 | 0.05 | 0.078 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.068 | 0.041 | 0.068 | Aryl hydrocarbon receptor antagonist | |||
| 0.157 | 0.13 | 0.21 | Aryl hydrocarbon receptor agonist | 0.21 0.097 DBMET03663 | DBMET03663 | |
| 0.062 | 0.036 | 0.062 | EphB4 antagonist | 0.051 0.048 DBMET03659 | ||
| 0.043 | 0.017 | 0.051 | VCAM-1 antagonist | 0.041 0.022 DBMET03659 0.051 0.009 DBMET03660 0.042 0.021 DBMET03663 0.039 0.029 DBMET03662 | DBMET03660 | |
| 0.043 | 0.017 | 0.051 | VCAM antagonist | 0.041 0.022 DBMET03659 0.051 0.009 DBMET03660 0.041 0.021 DBMET03663 0.039 0.028 DBMET03662 | DBMET03660 | |
| 0.031 | 0.005 | 0.031 | Sodium/hydrogen exchanger inhibitor | 0.019 0.01 DBMET03659 0.023 0.006 DBMET03660 0.024 0.006 DBMET03663 0.018 0.012 DBMET03662 | ||
| 0.041 | 0.016 | 0.041 | ATM kinase inhibitor | |||
| 0.049 | 0.026 | 0.049 | Dihydroorotase inhibitor | |||
| 0.039 | 0.016 | 0.039 | Calcium release-activated channel blocker | |||
| 0.026 | 0.004 | 0.026 | CC chemokine 9 receptor antagonist | 0.019 0.008 DBMET03660 0.022 0.005 DBMET03663 | ||
| 0.18 | 0.16 | 0.18 | Neuropeptide Y2 antagonist | |||
| 0.026 | 0.006 | 0.026 | Alpha 2c adrenoreceptor agonist | |||
| 0.091 | 0.073 | 0.091 | Chemokine receptor antagonist | |||
| 0.086 | 0.068 | 0.089 | Hepatocyte growth factor antagonist | 0.083 0.071 DBMET03659 0.089 0.064 DBMET03660 | DBMET03660 | |
| 0.071 | 0.053 | 0.071 | MAP kinase 14 inhibitor | |||
| 0.041 | 0.024 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.023 DBMET03660 | ||
| 0.131 | 0.114 | 0.131 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.058 | 0.041 | 0.058 | Botulinum neurotoxin type A inhibitor | 0.053 0.049 DBMET03663 | ||
| 0.084 | 0.068 | 0.084 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.031 | 0.016 | 0.031 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.022 DBMET03660 | ||
| 0.038 | 0.023 | 0.038 | Purinergic P2X7 antagonist | |||
| 0.072 | 0.058 | 0.072 | Potassium channel (Tandem pore domain) blocker | |||
| 0.053 | 0.04 | 0.053 | Bromodomain-containing protein 4 inhibitor | |||
| 0.06 | 0.047 | 0.06 | Phosphodiesterase VII inhibitor | |||
| 0.153 | 0.141 | 0.176 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.176 0.111 DBMET03660 | DBMET03660 | |
| 0.199 | 0.189 | 0.199 | Calpain 2 inhibitor | |||
| 0.061 | 0.051 | 0.061 | Transcription factor RelA inhibitor | 0.06 0.056 DBMET03659 0.061 0.053 DBMET03663 | ||
| 0.108 | 0.099 | 0.108 | Tyrosine-protein kinase receptor antagonist | |||
| 0.067 | 0.058 | 0.067 | MAP kinase 11 inhibitor | |||
| 0.035 | 0.029 | 0.035 | G protein-coupled receptor agonist | |||
| 0.099 | 0.092 | 0.104 | Cell adhesion inhibitor | 0.099 0.091 DBMET03660 0.097 0.095 DBMET03663 0.104 0.083 DBMET03662 | DBMET03662 | |
| 0.254 | 0.248 | 0.286 | Caspase 9 stimulant | 0.27 0.228 DBMET03659 0.286 0.209 DBMET03663 | DBMET03663 | |
| 0.032 | 0.027 | 0.032 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.062 | 0.057 | 0.062 | Potassium channel (ATP-sensitive) blocker | |||
| 0.044 | 0.039 | 0.044 | Purinergic P2X antagonist | |||
| 0.117 | 0.113 | 0.117 | Aurora-C kinase inhibitor | |||
| 0.096 | 0.092 | 0.147 | c-Src kinase inhibitor | 0.147 0.057 DBMET03659 | DBMET03659 | |
| 0.083 | 0.08 | 0.083 | DNA directed RNA polymerase inhibitor | |||
| 0.021 | 0.017 | 0.021 | Alpha 1a adrenoreceptor agonist | |||
| 0.027 | 0.025 | 0.027 | MAP3K8 inhibitor | |||
| 0.163 | 0.16 | 0.163 | Cardiotonic | |||
| 0.096 | 0.094 | 0.13 | Histone deacetylase class III inhibitor | 0.13 0.061 DBMET03660 0.117 0.072 DBMET03662 | DBMET03660 | |
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.019 | 0.017 | 0.02 | Follicle-stimulating hormone antagonist | 0.02 0.013 DBMET03663 | DBMET03663 | |
| 0.073 | 0.072 | 0.073 | Ca(v)2.2 blocker | |||
| 0.106 | 0.105 | 0.106 | Cytokine production inhibitor | |||
| 0.078 | 0.078 | 0.093 | Interleukin 5 antagonist | 0.088 0.057 DBMET03661 0.093 0.05 DBMET03662 | DBMET03662 | |
| 0.021 | 0.027 | 0.033 | CXC chemokine 2 receptor antagonist | 0.024 0.023 DBMET03660 0.033 0.012 DBMET03663 | DBMET03663 | |
| 0.035 | 0.042 | 0.051 | Phosphorylase inhibitor | 0.051 0.03 DBMET03662 | DBMET03662 | |
| 0.109 | 0.119 | 0.146 | Src kinase inhibitor | 0.146 0.086 DBMET03659 | DBMET03659 | |
| 0.032 | 0.044 | 0.039 | Nicotinic acid receptor 1 agonist | 0.039 0.029 DBMET03660 | DBMET03660 | |
| 0.14 | 0.156 | 0.191 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.191 0.106 DBMET03659 0.161 0.129 DBMET03663 | DBMET03659 | |
| 0.052 | 0.067 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 DBMET03659 | DBMET03659 | |
| 0.05 | 0.067 | 0.057 | Ca(v)3.2 blocker | 0.057 0.045 DBMET03663 | DBMET03663 | |
| 0.09 | 0.109 | 0.109 | Cyclin-dependent kinase 7 inhibitor | 0.109 0.093 DBMET03660 | DBMET03660 | |
| 0.117 | 0.138 | 0.126 | CC chemokine 6 receptor antagonist | 0.126 0.088 DBMET03663 | DBMET03663 | |
| 0.181 | 0.202 | 0.196 | Caspase 3 stimulant | 0.196 0.174 DBMET03663 | DBMET03663 | |
| 0.105 | 0.132 | 0.145 | CDC-like kinase 2 inhibitor | 0.145 0.097 DBMET03660 | DBMET03660 | |
| 0.073 | 0.101 | 0.082 | T cell inhibitor | 0.082 0.057 DBMET03659 | DBMET03659 | |
| 0.08 | 0.108 | 0.174 | AMP-activated protein kinase stimulant | 0.114 0.055 DBMET03660 0.089 0.087 DBMET03661 0.174 0.016 DBMET03662 | DBMET03662 | |
| 0.041 | 0.075 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.045 DBMET03660 | DBMET03660 | |
| 0.051 | 0.086 | 0.07 | Histone deacetylase SIRT2 inhibitor | 0.07 0.055 DBMET03660 | DBMET03660 | |
| 0.093 | 0.134 | 0.113 | CDC-like kinase 1 inhibitor | 0.113 0.103 DBMET03660 | DBMET03660 | |
| 0.093 | 0.135 | 0.132 | Histone deacetylase SIRT1 inhibitor | 0.132 0.078 DBMET03660 | DBMET03660 | |
| 0.035 | 0.087 | 0.054 | CXC chemokine 1 receptor antagonist | 0.054 0.03 DBMET03663 | DBMET03663 | |
| 0.042 | 0.098 | 0.057 | Prostaglandin F2 alpha antagonist | 0.057 0.051 DBMET03661 | DBMET03661 | |
| 0.119 | 0.177 | 0.163 | Dyrk kinase inhibitor | 0.163 0.124 DBMET03660 | DBMET03660 | |
| 0.157 | 0.228 | 0.302 | Angiogenesis inhibitor | 0.302 0.091 DBMET03659 0.208 0.161 DBMET03661 | DBMET03659 | |
| 0.095 | 0.168 | 0.131 | Hexokinase inhibitor | 0.131 0.103 DBMET03662 | DBMET03662 | |
| 0.153 | 0.246 | 0.186 | Tyrosine 3 hydroxylase inhibitor | 0.182 0.172 DBMET03659 0.186 0.163 DBMET03660 0.182 0.172 DBMET03663 | DBMET03660 | |
| 0.041 | 0.15 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 DBMET03663 | DBMET03663 | |
| 0.071 | 0.203 | 0.117 | Peroxidase inhibitor | 0.117 0.103 DBMET03659 | DBMET03659 | |
| 0.037 | 0.18 | 0.082 | Potassium channel large-conductance Ca-activated activator | 0.082 0.033 DBMET03663 | DBMET03663 | |
| 0.061 | 0.247 | 0.12 | Anticoagulant | 0.12 0.112 DBMET03662 | DBMET03662 | |
| 0.007 | 0.274 | 0.043 | Nicotinic acid receptor 2 agonist | 0.043 0.018 DBMET03660 | DBMET03660 | |
| 0.08 | 0.355 | 0.252 | Hypoglycemic | 0.214 0.1 DBMET03661 0.252 0.076 DBMET03662 | DBMET03662 | |
| 0.015 | 0.292 | 0.056 | Purinergic P2X2 antagonist | 0.056 0.054 DBMET03660 | DBMET03660 | |
| 0.018 | 0.398 | 0.157 | Glutamate receptor antagonist | 0.157 0.046 DBMET03663 | DBMET03663 | |
| 0.013 | 0.572 | 0.099 | Estrogen receptor beta antagonist | 0.099 0.066 DBMET03659 | DBMET03659 | |
| 0.005 | 0.658 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.009 DBMET03663 | DBMET03663 | |
| 0.005 | 0.676 | 0.102 | Selectin antagonist | 0.064 0.046 DBMET03661 0.102 0.027 DBMET03662 | DBMET03662 | |
| 0.007 | 0.698 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET03661 0.054 0.036 DBMET03662 | DBMET03662 | |
| 0.007 | 0.844 | 0.139 | Thrombolytic | 0.139 0.091 DBMET03662 | DBMET03662 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |